Santen Pharmaceutical Co., Ltd.

TSE:4536.T

1698 (JPY) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Assets:
Current Assets:
Cash & Cash Equivalents 94,58257,90383,01462,88891,43070,79669,28353,29799,79865,92363,50950,88466,23565,55856,67737,11735,48334,29534,58323,948
Short Term Investments 3797741,29352745226747233323418713,11111,00712,73913,3328,99811,39615,86816,91411,2019,046
Cash and Short Term Investments 94,58258,67784,30763,41591,88271,06369,75553,630100,03266,11076,62061,89178,97478,89065,67548,51351,35151,20945,78432,994
Net Receivables 90,539107,16599,59195,99286,99984,61878,65470,97065,99861,701043,83937,92238,97935,26836,01035,61335,03434,42235,607
Inventory 43,18539,35237,14141,57535,28235,23530,63628,50224,99620,13320,03020,94717,94914,70213,62212,23411,33210,3579,8379,826
Other Current Assets 7,8338,1328,3875,2494,3933,8264,3223,9093,7132,7287,2735,9055,4435,0974,2674,2964,4584,2203,8494,308
Total Current Assets 236,139213,326229,426206,231218,556194,742183,367157,011194,739150,672156,006132,582140,288137,668118,832101,053102,754100,82093,89282,735
Non-Current Assets:
Property, Plant & Equipment, Net 71,57666,17356,28739,48935,60131,69929,70628,55027,99129,10427,62827,42025,52324,95626,57428,66429,84830,48530,39532,676
Goodwill 8,3037,38513,71526,85822,12722,71322,29522,7706,4406,5786,2975,9365,8010003003857091,015
Intangible Assets 75,51696,309130,217112,876119,850131,110134,495102,80783,68184,43310,2888,1877,0739911,2301,5481,9322,3862,2412,301
Goodwill and Intangible Assets 83,81996,309130,217112,876119,850131,110134,495102,80783,68184,43316,58514,12312,8749911,2301,5482,2322,7712,9503,316
Long Term Investments 24,40642,56040,94440,93332,66131,86335,30329,55644,30134,5388,6287,166-328-1,1913,2414221,0814,1056,5145,267
Tax Assets 10,7652,8103,1032,8242,1001,7712,2642,3962,3452,9785,4884,4606,5007,5386,7026,4091,82216,9643791,051
Other Non-Current Assets 8,994100013,3272,4582,3422,47516,76813,88613,94414,83910,29912,91618,8103,95316,32814,934
Total Non-Current Assets 199,560207,853230,551196,122190,212196,444205,095165,767160,660153,52875,09767,05558,51347,13348,04649,95953,79358,27856,56657,244
Total Assets 435,699421,179459,976402,353408,768391,186388,463322,778355,399304,200231,104199,639198,801184,801166,878151,012156,547159,098150,458139,979
Liabilities & Equity:
Current Liabilities:
Account Payables 24,04225,28224,42024,25921,88723,10129,74317,88324,50420,25019,0729,2668,07414,47513,53613,43213,32314,66114,93814,699
Short Term Debt 2,74800005004,0989,3310000005436555,168168168268
Tax Payables 5,1276,7454,1985,4586,8487,1857,6563,27920,4316,7298,1693,0385,2824,6316,6184,1634,3233,9174,9463,413
Deferred Revenue 0-3,056-13,965-2,912-5,726-500-4,098-9,331-9,540-11,76700009,3866,8227,0096,4617,5106,093
Other Current Liabilities 60,87957,47767,20348,83238,86229,87720,70422,94128,29529,36111,85214,70714,0694,9984,5894,1893,7473,6234,0583,841
Total Current Liabilities 92,79689,50495,82178,54967,59760,66362,20153,43473,23056,34039,09327,01127,42524,10425,28622,43926,56122,36924,11022,221
Non-Current Liabilities:
Long Term Debt 32,410000-21,3333,5633,500000-6,77687-3,662-3,727-3,292-2,855-2,1923,3603,7414,757
Deferred Revenue Non-Current 7387,27711,1619,55127,93523,204-3,500-7,598-12,914-25,3516,4234,0723,8423,8793,3662,8982,3021,9181,7051,857
Deferred Tax Liabilities Non-Current 1,3771,5922,5263,2907,2289,38912,9092,5963,9882,8742,7962,2691,996201520174262023
Other Non-Current Liabilities 7,95629,50913,6247,2031,48324,99922,29615,46018,17233,2071,5255,1415622425342444394625401,025
Total Non-Current Liabilities 37,53438,37827,31116,75438,61137,95138,70515,46022,16036,08110,8037,4976,5154,2933,9893,2052,8688,0847,7119,519
Total Liabilities 130,330127,882123,13295,303106,20898,614100,90668,89495,39092,42149,89634,50833,94028,39729,27525,64429,42930,45331,82131,740
Equity:
Preferred Stock 0256,198307,802287,150289,500274,44000000000000000
Common Stock 8,7778,7028,6728,5258,3668,2528,0327,7927,6957,3837,2647,0806,6946,6146,5386,4576,4186,3826,3196,247
Retained Earnings 240,029238,071290,477270,757273,422258,659249,225223,418221,945178,840160,115151,001156,030147,578133,053121,133117,786111,645104,13395,901
Accumulated Other Comprehensive Income/Loss 48,41237,78129,68620,43513,36516,46019,92215,62722,00317,4975,880-72200000000
Other Total Stockholders Equity 8,8369,4258,6535,3877,7127,5298,6446,3638,3658,0591,9487,7728,0457,967-1,988-2,2222,19310,6186,9246,868
Total Shareholders Equity 306,054293,979337,488307,585302,865290,900285,823253,065260,009211,779181,208165,131164,861156,404137,603125,368127,118128,645118,637108,239
Total Equity 305,369293,296336,843307,050302,560292,572287,557253,884260,009211,779181,208165,131164,861156,404137,603125,368127,118128,645118,637108,239
Total Liabilities & Shareholders Equity 435,699421,861460,620402,353408,768391,186388,463322,778355,399304,200231,104199,639198,801184,801166,878151,012156,547159,098150,458139,979